1-161543076-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000569.8(FCGR3A):c.701G>T(p.Arg234Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 1,613,144 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000569.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FCGR3A | NM_000569.8 | c.701G>T | p.Arg234Leu | missense_variant | 5/5 | ENST00000443193.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FCGR3A | ENST00000443193.6 | c.701G>T | p.Arg234Leu | missense_variant | 5/5 | 1 | NM_000569.8 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151772Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251038Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135666
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461372Hom.: 1 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 726988
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151772Hom.: 0 Cov.: 32 AF XY: 0.0000405 AC XY: 3AN XY: 74094
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2023 | The c.809G>T (p.R270L) alteration is located in exon 5 (coding exon 5) of the FCGR3A gene. This alteration results from a G to T substitution at nucleotide position 809, causing the arginine (R) at amino acid position 270 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at